Search filters

List of works by Kazuhiro Araki

A case of respiratory akathisia in a cancer patient: a case report.

scientific article

A phase I study of infusional 5-fluorouracil, leucovorin, oxaliplatin and irinotecan in Japanese patients with advanced colorectal cancer who harbor UGT1A1*1/*1,*1/*6 or *1/*28

scientific article published on 12 April 2012

Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI).

scientific article

Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer

scientific article (publication date: 2010)

CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1.

scientific article published in May 2008

Can strategies targeting cleaved MUC1 overcome resistance to trastuzumab?

scientific article published on 16 October 2009

Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung

scientific article published on 01 July 2003

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients.

scientific article published on 22 July 2015

Efficacy of fulvestrant 500 mg in Japanese postmenopausal advanced/recurrent breast cancer patients and factors associated with prolonged time-to-treatment failure

scientific article published on 11 November 2015

First clinical pharmacokinetic dose-escalation study of sagopilone, a novel, fully synthetic epothilone, in Japanese patients with refractory solid tumors ⬇️

scientific article published on 04 December 2011

First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer.

scientific article published on 26 June 2017

Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung ⬇️

scientific article published on May 1, 2003

Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience.

scientific article published on 21 April 2015

Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer

scientific article published on 04 April 2007

Imatinib alleviated pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in a patient with metastatic breast cancer

scientific article

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

scientific article published on 12 February 2018

Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer.

scientific article published in October 2014

Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

scientific article published on 21 June 2016

Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer

scientific article published on 31 October 2017

Novel single nucleotide polymorphism of UGT1A7 gene in Japanese.

scientific article

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer

scientific article

Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer.

scientific article

Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumors.

scientific article

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer

scientific article

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel

scientific article published on 16 October 2018

Re: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of three pivotal, randomised, phase 3 trials ⬇️

scientific article published on March 27, 2013

Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

scientific article published on 29 January 2008

Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel

scientific article published on 08 March 2018

Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes

scientific article published on 25 May 2016

Trastuzumab Rechallenge After Lapatinib- and Trastuzumab-Resistant Disease Progression in HER2-Positive Breast Cancer.

scientific article published on 18 June 2015

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.

scientific article published on 8 September 2017

UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer ⬇️

scientific article published on October 19, 2010

Paulina is supported by:

About Paulina

Help